Ionis Pharmaceuticals IONS Early Repayment Of Convertible Debt
Early Repayment Of Convertible Debt at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept ions:EarlyRepaymentOfConvertibleDebt.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's early repayment of convertible debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Ionis Pharmaceuticals's early repayment of convertible debt?
- Ionis Pharmaceuticals (IONS) reported early repayment of convertible debt of $66.91M in Q4 2025.
- What does early repayment of convertible debt mean?
- Cash paid to retire convertible debt before it is due.
- How do you interpret early repayment of convertible debt?
- An increase suggests the company is actively managing its capital structure or has excess liquidity to reduce debt obligations.
- How does early repayment of convertible debt compare across companies?
- Common in biotech companies managing capital structures; peers often report this during refinancing cycles.